INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 418m ago
House PTR18m ago
SEC 13F17m ago
Robinhood Chain17m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$84K
599 sh
Jan 13, 2026
Page 1488 of 1814
← PrevNext →
Jan 14, 2026
traded Jan 13, 2026
+1d
SEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$84K
600 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

5
DP
Duffy Sean P.Director, Chief Executive Officer
OMDAOmada Health, Inc.
Option exercise
M—
40.8K sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

5
AE
Allison EricChief Product Officer
JOBYJoby Aviation, Inc.
Option exercise
M—
2,960 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
KA
Kapadia Sandip AHead of Actuarial
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
MM
Momper Sara MarieVP, CAO
HPHelmerich & Payne, Inc.
Grant or award
A—
426 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
KA
Kapadia Sandip AHead of Actuarial
SKWDSkyward Specialty Insurance Group, Inc.
Option exercise
M—
5,000 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
IC
Indelicarto Thomas CEVP, Gen Counsel & Secretary
VRSNVERISIGN INC/CA
Open-market sale · 10b5-1 plan
SELL$42K
166 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

5
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$286K
36.6K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

5
MM
Momper Sara MarieVP, CAO
HPHelmerich & Payne, Inc.
Tax withholding
F$4,434
145 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$706K
45.0K sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

4
LP
Lee Anthony PDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$496K
6,020 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$14K
100 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$15K
100 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$43K
300 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$29K
200 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$28K
201 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$43K
300 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Option exercise · 10b5-1 plan
M—
16.1K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

3
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
21.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$29K
200 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$14K
100 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$28K
200 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$15K
100 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

2
MC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF
OLMAOlema Pharmaceuticals, Inc.
Option exercise
M—
50.0K sh
Jan 14, 2026Jan 14, 2026
traded Jan 14, 2026
+0dSEC Form 4

Evidence

2
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$178K
21.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

1
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Option exercise
M—
200.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

1
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Option exercise
M—
200.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

1
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$7,022
48 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

1
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$42K
500 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

1
MJ
Murry Stefan J.Chief Financial Officer
AAOIAPPLIED OPTOELECTRONICS, INC.
Open-market sale · 10b5-1 plan
SELL$33K
934 sh
Jan 13, 2026Jan 14, 2026
traded Jan 13, 2026
+1dSEC Form 4

Evidence

0
Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner
ROKUROKU, INC
Derivative conversion · 10b5-1 plan
C—
75.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

0
PK
Piskel KyleChief Financial Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$52K
4,290 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

0
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
7,723 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

0
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$94K
7,723 sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

0
Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner
ROKUROKU, INC
Derivative conversion · 10b5-1 plan
C—
75.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

0
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.2K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence

0
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$57K
14.2K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC Form 4

Evidence